Michael McCaleb

Company: Ionis Pharmaceuticals

Job title: Vice President, Clinical Development, & Head of Ophthalmology Disease Franchise

Seminars:

Spotlight on IONIS-FB-LRx – Systemic Administration of a RNA-Targeting Therapeutic for GA 12:15 pm

Discuss the novel approach for addressing systemic etiologies of GA Examine the clinical utility of Antisense (ASO) therapeutics for common and rare diseases Analyses of complement regulation in Phase 1 studies with the factor B ASO Update on ongoing Ph 2 GA trial, the GOLDEN StudyRead more

day: Track 2 Day 1 AM